Plavix Could Face Rival Prasugrel In Second Half

Combined Lilly/Daiichi sales force stands ready to support antiplatelet drug’s launch when approval comes, Lilly head of cardiovascular research tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet